- Home
- ANVS vs DTSQ Comparison
ANVS vs DTSQ Comparison
Compare ANVS & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- DTSQ
- Stock Information
- Founded
- ANVS 2008
- DTSQ 2022
- Country
- ANVS United States
- DTSQ United States
- Employees
- ANVS N/A
- DTSQ N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- ANVS Health Care
- DTSQ
- Exchange
- ANVS Nasdaq
- DTSQ NYSE
- Market Cap
- ANVS 92.6M
- DTSQ 89.8M
- IPO Year
- ANVS 2020
- DTSQ 2024
- Fundamental
- Price
- ANVS $5.01
- DTSQ $10.11
- Analyst Decision
- ANVS Strong Buy
- DTSQ
- Analyst Count
- ANVS 6
- DTSQ 0
- Target Price
- ANVS $29.67
- DTSQ N/A
- AVG Volume (30 Days)
- ANVS 488.6K
- DTSQ 38.5K
- Earning Date
- ANVS 11-08-2024
- DTSQ 01-01-0001
- Dividend Yield
- ANVS N/A
- DTSQ N/A
- EPS Growth
- ANVS N/A
- DTSQ N/A
- EPS
- ANVS N/A
- DTSQ 0.17
- Revenue
- ANVS N/A
- DTSQ N/A
- Revenue This Year
- ANVS N/A
- DTSQ N/A
- Revenue Next Year
- ANVS N/A
- DTSQ N/A
- P/E Ratio
- ANVS N/A
- DTSQ $60.78
- Revenue Growth
- ANVS N/A
- DTSQ N/A
- 52 Week Low
- ANVS $4.21
- DTSQ $9.96
- 52 Week High
- ANVS $20.00
- DTSQ $10.12
- Technical
- Relative Strength Index (RSI)
- ANVS 44.02
- DTSQ N/A
- Support Level
- ANVS $4.61
- DTSQ N/A
- Resistance Level
- ANVS $4.95
- DTSQ N/A
- Average True Range (ATR)
- ANVS 0.38
- DTSQ 0.00
- MACD
- ANVS 0.07
- DTSQ 0.00
- Stochastic Oscillator
- ANVS 40.40
- DTSQ 0.00
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.